Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoi…
Drug Manufacturers - Specialty & Generic
US, Ann Arbor [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Esperion Therapeutics, Inc. (ESPR) to it's peer group.
Peer Group
CTLT ITCI ALKS NBIX ELAN PBH RMTI ANIP PAHC LFCR DCPH COLL IRWD EGRX PCRX AGRX SIGA
Compare Together
Loading...